Similar Articles

Tumour Necrosis Factor-Alpha Alone is not Predictive of Relapses in Multiple Sclerosis.

Egemen İDİMAN, Hakkı BAHAR, İhsan Şükrü ŞENGÜN, Göksemin ACAR, Barış BAKLAN, Murat SAYAN, Huriye AYDIN, Tuncer TOKLU, Serkan ÖZAKBAŞ

Issue: 2004, Volume 10 - Issue 1
0 190

Demographic and Clinical Features in Primary Progressive Multiple Sclerosis

Serkan ÖZAKBAŞ, Egemen İDİMAN, Burak PAKÖZ, Burcu ÖRMECİ, Beril DÖNMEZ

Issue: 2003, Volume 9 - Issue 3
0 216

Supportive Group Therapy in Multiple Sclerosis

Şule Özden TOPKAYA, Meral OĞUZ, Fatma UZUNEL, Serkan ÖZAKBAŞ, Köksal ALPTEKİN, Egemen İDİMAN

Issue: 2003, Volume 9 - Issue 1
0 188

Cerebrovascular Disease in Childhood: Etiology

Pınar ÇE, İpek İNCİ, Muhteşem GEDİZLİOĞLU, Hatice DERELİ, Esra ARPACI, Metin AKINCILAR

Issue: 2002, Volume 8 - Issue 4
0 174

Flash-Electroretinographic Investigation of Retina Dysfunction in Subjects With Multiple Sclerosis

Temel TOMBUL, Ömer ANLAR, Adnan ÇINAL, Osman TANIK

Issue: 2002, Volume 8 - Issue 4
0 196

Necessity of Psychological Support in Patients with Multiple Sclerosis

Şule Özden TOPKAYA, Meral OĞUZ, Fatma UZUNYEL, Serkan ÖZAKBAŞ, Köksal ALPTEKİN, Egemen İDİMAN

Issue: 2002, Volume 8 - Issue 4
0 186

Causes of Death in Multiple Sclerosis: Cross-sectional Analysis of 16 Years Period

Serkan ÖZAKBAŞ, Burak PAKÖZ, İhsan Şükrü ŞENGÜN, Barış BAKLAN, Göksemin DEMİR, Bülent ÜNLÜ, Zuhal BAHAR, Egemen İDİMAN

Issue: 2002, Volume 8 - Issue 2
0 204

Experiences of lnterferon Beta-1b Treatment After 5-Year Follow-U

Serkan ÖZAKBAŞ, Egemen İDİMAN, Burak PAKÖZ, Berril DÖNMEZ, Utku UYSAL

Issue: 2002, Volume 8 - Issue 1
0 184

A Case of Mu/tiple Sclerosis Presenting As Unilateral Papillitis

Nurgül YILMAZ, Ebru ÖZAY, Funda AÇIKGÖZ, Nursel AYDIN

Issue: 2002, Volume 8 - Issue 1
0 215

Multimodal Evoked Potentialsin Follow-up of Treatment of Multiple Sclerosis With lnterferon Beta-1 a

Serkan ÖZAKBAŞ, Raif ÇAKMUR, Vesile ÖZTÜRK, Egemen İDİMAN, Fethi İDİMAN

Issue: 2001, Volume 7 - Issue 1
0 159

lnterferon Beta-1b In TheTreatment Of Relapsing Remitting Multiple Sclerosis:Clinical and Magnetic Resonance lmaging Results

Serkan ÖZAKBAŞ, Egemen İDİMAN, Handan ÇAKMAKÇI, İlhami KOVANLIKAYA

Issue: 2001, Volume 7 - Issue 1
0 198

Cytokines in Multiple Sclerosis

A. ALTINTAŞ, O. KANTARCI, S. SAİP, A. SİVA, S. ÖZTUZCU, N. HEKİM, P. BOZKURT

Issue: 2000, Volume 6 - Issue 4
0 155

Beta lnterferon-lA Treatment in Multipl Sclerosis and Cognitive Functions

E. İDİMAN, G. G. YENER, G. AKDAL, S. ÖZAKBAŞ

Issue: 2000, Volume 6 - Issue 4
0 169

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 149

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 144

Changes of Pattern Reversal Evoked Potentials in Estrogen Replacement Therapy

Hikmet YILMAZ, Hatica MAVİOĞLU, Esin ERKİN, Selman LAÇİN

Issue: 1998, Volume 4 - Issue 3-4
0 142

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 214

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 149

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 194

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 146